HopeStage
Back to all studies
CompletedNCT00237861

Newer or older antipsychotics for schizophrenia

About this titleRead the official source — NCT00237861
Medication study
The study in practice

Understand this study

Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
Not clearly listed
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Not clearly listed
Age range
Not clearly listed
Official registry ID
NCT00237861
Official title
Show the full official title

Effectiveness of Atypical Vs Conventional Antipsychotics

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Did this study involve medication?

Yes. The study involved medication, including risperidone, olanzapine and quetiapine.

Want to explore more studies?

Explore studies